PAUL J MADDON Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for PAUL J MADDON.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of PAUL J MADDON. PAUL J MADDON is CEO & CSO in PROGENICS PHARMACEUTICALS INC ($PGNX) and Chief Executive Officer/CSO in PROGENICS PHARMACEUTICALS INC ($PGNX) and CSO&ViceChairmanBOD in PROGENICS PHARMACEUTICALS INC ($PGNX) and Director in PROGENICS PHARMACEUTICALS INC ($PGNX).
Latest Insider Trading Transactions of PAUL J MADDON
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 19 2014 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Director | Option Exercise | A | 4.47 | 20,000 | 89,400 | 20,000 | |
Jun 20 2013 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Director | Option Exercise | A | 4.76 | 20,000 | 95,200 | 20,000 | |
Jun 14 2012 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Director | Option Exercise | A | 7.93 | 10,000 | 79,300 | 10,000 | |
Jul 06 2011 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | CSO&ViceChairmanBOD | Option Exercise | A | 7.40 | 85,000 | 629,000 | 85,000 | |
Dec 01 2010 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Buy | P | 4.90 | 5,000 | 24,500 | 854,057 | 849.1 K to 854.1 K (+0.59 %) |
Nov 02 2010 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Buy | P | 4.76 | 5,000 | 23,800 | 849,057 | 844.1 K to 849.1 K (+0.59 %) |
Oct 04 2010 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Buy | P | 4.99 | 5,000 | 24,950 | 844,057 | 839.1 K to 844.1 K (+0.60 %) |
Sep 02 2010 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Buy | P | 4.10 | 5,000 | 20,500 | 839,057 | 834.1 K to 839.1 K (+0.60 %) |
Aug 02 2010 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Buy | P | 4.75 | 5,000 | 23,750 | 834,057 | 829.1 K to 834.1 K (+0.60 %) |
Jul 19 2010 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Buy | P | 4.98 | 28 | 139 | 829,057 | 829 K to 829.1 K (0.00 %) |
Jul 19 2010 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Buy | P | 4.99 | 4,972 | 24,810 | 829,029 | 824.1 K to 829 K (+0.60 %) |
Jul 06 2010 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Option Exercise | A | 5.35 | 100,000 | 535,000 | 150,000 | |
Jul 06 2010 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Option Exercise | A | 5.35 | 50,000 | 267,500 | 50,000 | |
Jun 02 2010 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Buy | P | 4.99 | 5,000 | 24,950 | 824,057 | 819.1 K to 824.1 K (+0.61 %) |
May 21 2010 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Buy | P | 4.93 | 4,495 | 22,160 | 819,057 | 814.6 K to 819.1 K (+0.55 %) |
May 21 2010 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Buy | P | 4.89 | 505 | 2,469 | 814,562 | 814.1 K to 814.6 K (+0.06 %) |
Apr 07 2010 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Grant | A | 0.00 | 44,723 | 0 | 849,665 | 804.9 K to 849.7 K (+5.56 %) |
Oct 19 2009 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Buy | P | 4.88 | 18,500 | 90,243 | 804,942 | 786.4 K to 804.9 K (+2.35 %) |
Jul 06 2009 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Option Exercise | A | 5.33 | 175,000 | 932,750 | 175,000 | |
Mar 23 2009 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Grant | A | 0.00 | 66,294 | 0 | 786,442 | 720.1 K to 786.4 K (+9.21 %) |
Jul 03 2008 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Option Exercise | A | 16.05 | 75,000 | 1,203,750 | 75,000 | |
Jul 03 2008 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Grant | A | 0.00 | 25,000 | 0 | 720,148 | 695.1 K to 720.1 K (+3.60 %) |
Oct 17 2007 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Option Exercise | M | 5.33 | 15,000 | 79,950 | 0 | |
Oct 17 2007 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Sell | S | 23.49 | 15,000 | 352,380 | 695,148 | 710.1 K to 695.1 K (-2.11 %) |
Oct 17 2007 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Buy | M | 5.33 | 15,000 | 79,950 | 710,148 | 695.1 K to 710.1 K (+2.16 %) |
Oct 03 2007 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Option Exercise | M | 5.33 | 12,000 | 63,960 | 15,000 | |
Oct 03 2007 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Option Exercise | M | 19.03 | 1,995 | 37,965 | 0 | |
Oct 03 2007 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Payment of Exercise | F | 22.39 | 1,816 | 40,660 | 695,148 | 697 K to 695.1 K (-0.26 %) |
Oct 03 2007 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Buy | M | 19.03 | 1,995 | 37,965 | 696,964 | 695 K to 697 K (+0.29 %) |
Oct 03 2007 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Sell | S | 22.03 | 12,000 | 264,312 | 694,969 | 707 K to 695 K (-1.70 %) |
Oct 03 2007 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Buy | M | 5.33 | 12,000 | 63,960 | 706,969 | 695 K to 707 K (+1.73 %) |
Sep 19 2007 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Option Exercise | M | 5.33 | 12,000 | 63,960 | 27,000 | |
Sep 19 2007 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Sell | S | 23.39 | 12,000 | 280,728 | 694,969 | 707 K to 695 K (-1.70 %) |
Sep 19 2007 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Buy | M | 5.33 | 12,000 | 63,960 | 706,969 | 695 K to 707 K (+1.73 %) |
Sep 06 2007 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Option Exercise | M | 5.33 | 12,000 | 63,960 | 39,000 | |
Sep 06 2007 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Sell | S | 23.77 | 12,000 | 285,180 | 694,969 | 707 K to 695 K (-1.70 %) |
Sep 06 2007 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Buy | M | 5.33 | 12,000 | 63,960 | 706,969 | 695 K to 707 K (+1.73 %) |
Aug 16 2007 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Option Exercise | M | 5.33 | 12,000 | 63,960 | 51,000 | |
Aug 16 2007 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Sell | S | 23.16 | 12,000 | 277,860 | 694,969 | 707 K to 695 K (-1.70 %) |
Aug 16 2007 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Buy | M | 5.33 | 12,000 | 63,960 | 706,969 | 695 K to 707 K (+1.73 %) |
Aug 02 2007 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Option Exercise | M | 5.33 | 12,000 | 63,960 | 63,000 | |
Aug 02 2007 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Sell | S | 21.23 | 12,000 | 254,784 | 694,969 | 707 K to 695 K (-1.70 %) |
Aug 02 2007 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Buy | M | 5.33 | 12,000 | 63,960 | 706,969 | 695 K to 707 K (+1.73 %) |
Jul 18 2007 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Option Exercise | M | 5.33 | 12,000 | 63,960 | 75,000 | |
Jul 18 2007 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Sell | S | 21.46 | 12,000 | 257,472 | 694,969 | 707 K to 695 K (-1.70 %) |
Jul 18 2007 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Buy | M | 5.33 | 12,000 | 63,960 | 706,969 | 695 K to 707 K (+1.73 %) |
Jul 05 2007 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Option Exercise | A | 22.01 | 112,500 | 2,476,125 | 112,500 | |
Jul 05 2007 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Option Exercise | M | 5.33 | 12,000 | 63,960 | 87,000 | |
Jul 05 2007 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Option Exercise | M | 18.71 | 1,986 | 37,158 | 0 | |
Jul 05 2007 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Sell | S | 21.68 | 12,000 | 260,112 | 694,969 | 707 K to 695 K (-1.70 %) |
Jul 05 2007 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Buy | M | 5.33 | 12,000 | 63,960 | 706,969 | 695 K to 707 K (+1.73 %) |
Jul 05 2007 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Grant | A | 0.00 | 37,500 | 0 | 694,969 | 657.5 K to 695 K (+5.70 %) |
Jul 05 2007 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Payment of Exercise | F | 22.01 | 1,807 | 39,772 | 657,469 | 659.3 K to 657.5 K (-0.27 %) |
Jul 05 2007 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Buy | M | 18.71 | 1,986 | 37,158 | 659,276 | 657.3 K to 659.3 K (+0.30 %) |
Jun 04 2007 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Option Exercise | M | 5.33 | 12,000 | 63,960 | 99,000 | |
Jun 04 2007 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Sell | S | 21.75 | 12,000 | 261,012 | 657,290 | 669.3 K to 657.3 K (-1.79 %) |
Jun 04 2007 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Buy | M | 5.33 | 12,000 | 63,960 | 669,290 | 657.3 K to 669.3 K (+1.83 %) |
May 16 2007 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Option Exercise | M | 5.33 | 12,000 | 63,960 | 111,000 | |
May 16 2007 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Sell | S | 21.90 | 12,000 | 262,800 | 657,290 | 669.3 K to 657.3 K (-1.79 %) |
May 16 2007 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Buy | M | 5.33 | 12,000 | 63,960 | 669,290 | 657.3 K to 669.3 K (+1.83 %) |
May 03 2007 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Option Exercise | M | 5.33 | 12,000 | 63,960 | 123,000 | |
May 03 2007 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Sell | S | 25.61 | 12,000 | 307,356 | 657,290 | 669.3 K to 657.3 K (-1.79 %) |
May 03 2007 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Buy | M | 5.33 | 12,000 | 63,960 | 669,290 | 657.3 K to 669.3 K (+1.83 %) |
Apr 17 2007 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Option Exercise | M | 5.33 | 12,000 | 63,960 | 135,000 | |
Apr 17 2007 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Sell | S | 26.80 | 12,000 | 321,588 | 657,290 | 669.3 K to 657.3 K (-1.79 %) |
Apr 17 2007 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Buy | M | 5.33 | 12,000 | 63,960 | 669,290 | 657.3 K to 669.3 K (+1.83 %) |
Apr 04 2007 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Option Exercise | M | 5.33 | 12,000 | 63,960 | 147,000 | |
Apr 04 2007 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Option Exercise | A | 20.13 | 1,809 | 36,415 | 1,809 | |
Apr 04 2007 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Option Exercise | M | 20.13 | 1,754 | 35,308 | 0 | |
Apr 04 2007 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Payment of Exercise | F | 24.10 | 1,581 | 38,102 | 657,290 | 658.9 K to 657.3 K (-0.24 %) |
Apr 04 2007 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Buy | M | 20.13 | 1,754 | 35,308 | 658,871 | 657.1 K to 658.9 K (+0.27 %) |
Apr 04 2007 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Sell | S | 23.85 | 12,000 | 286,152 | 657,117 | 669.1 K to 657.1 K (-1.79 %) |
Apr 04 2007 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Buy | M | 5.33 | 12,000 | 63,960 | 669,117 | 657.1 K to 669.1 K (+1.83 %) |
Mar 19 2007 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Option Exercise | M | 5.33 | 12,000 | 63,960 | 159,000 | |
Mar 19 2007 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Sell | S | 22.95 | 12,000 | 275,424 | 657,117 | 669.1 K to 657.1 K (-1.79 %) |
Mar 19 2007 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Buy | M | 5.33 | 12,000 | 63,960 | 669,117 | 657.1 K to 669.1 K (+1.83 %) |
Mar 02 2007 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Option Exercise | M | 5.33 | 12,000 | 63,960 | 171,000 | |
Mar 02 2007 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Sell | S | 26.49 | 12,000 | 317,832 | 657,117 | 669.1 K to 657.1 K (-1.79 %) |
Mar 02 2007 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Buy | M | 5.33 | 12,000 | 63,960 | 669,117 | 657.1 K to 669.1 K (+1.83 %) |
Feb 22 2007 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Grant | A | 0.00 | 15,957 | 0 | 657,117 | 641.2 K to 657.1 K (+2.49 %) |
Feb 20 2007 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Option Exercise | M | 5.33 | 12,000 | 63,960 | 183,000 | |
Feb 20 2007 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Sell | S | 29.89 | 12,000 | 358,716 | 641,160 | 653.2 K to 641.2 K (-1.84 %) |
Feb 20 2007 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Buy | M | 5.33 | 12,000 | 63,960 | 653,160 | 641.2 K to 653.2 K (+1.87 %) |
Feb 02 2007 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Option Exercise | M | 5.33 | 12,000 | 63,960 | 195,000 | |
Feb 02 2007 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Sell | S | 29.89 | 12,000 | 358,632 | 641,160 | 653.2 K to 641.2 K (-1.84 %) |
Feb 02 2007 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Buy | M | 5.33 | 12,000 | 63,960 | 653,160 | 641.2 K to 653.2 K (+1.87 %) |
Jan 18 2007 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Option Exercise | M | 5.33 | 12,000 | 63,960 | 207,000 | |
Jan 18 2007 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Sell | S | 28.58 | 12,000 | 342,912 | 641,160 | 653.2 K to 641.2 K (-1.84 %) |
Jan 18 2007 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Buy | M | 5.33 | 12,000 | 63,960 | 653,160 | 641.2 K to 653.2 K (+1.87 %) |
Jan 05 2007 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Option Exercise | M | 5.33 | 12,000 | 63,960 | 219,000 | |
Jan 05 2007 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Option Exercise | A | 25.74 | 1,441 | 37,091 | 1,441 | |
Jan 05 2007 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Option Exercise | M | 21.88 | 1,614 | 35,314 | 0 | |
Jan 05 2007 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Payment of Exercise | F | 26.66 | 1,441 | 38,417 | 641,160 | 642.6 K to 641.2 K (-0.22 %) |
Jan 05 2007 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Buy | M | 21.88 | 1,614 | 35,314 | 642,601 | 641 K to 642.6 K (+0.25 %) |
Jan 05 2007 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Sell | S | 25.68 | 12,000 | 308,124 | 640,987 | 653 K to 641 K (-1.84 %) |
Jan 05 2007 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Buy | M | 5.33 | 12,000 | 63,960 | 652,987 | 641 K to 653 K (+1.87 %) |
Dec 19 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Option Exercise | M | 5.33 | 12,000 | 63,960 | 231,000 | |
Dec 19 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Sell | S | 26.14 | 12,000 | 313,668 | 640,987 | 653 K to 641 K (-1.84 %) |
Dec 19 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Buy | M | 5.33 | 12,000 | 63,960 | 652,987 | 641 K to 653 K (+1.87 %) |
Dec 05 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Option Exercise | M | 5.33 | 5,000 | 26,650 | 243,000 | |
Dec 05 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Option Exercise | M | 5.33 | 7,000 | 37,310 | 248,000 | |
Dec 05 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Sell | S | 26.91 | 5,000 | 134,565 | 640,987 | 646 K to 641 K (-0.77 %) |
Dec 05 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Buy | M | 5.33 | 5,000 | 26,650 | 645,987 | 641 K to 646 K (+0.78 %) |
Dec 05 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Sell | S | 26.75 | 7,000 | 187,278 | 640,987 | 648 K to 641 K (-1.08 %) |
Dec 05 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Buy | M | 5.33 | 7,000 | 37,310 | 647,987 | 641 K to 648 K (+1.09 %) |
Nov 17 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Option Exercise | M | 5.33 | 5,000 | 26,650 | 255,000 | |
Nov 17 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Option Exercise | M | 5.33 | 7,000 | 37,310 | 260,000 | |
Nov 17 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Sell | S | 29.26 | 5,000 | 146,290 | 640,987 | 646 K to 641 K (-0.77 %) |
Nov 17 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Buy | M | 5.33 | 5,000 | 26,650 | 645,987 | 641 K to 646 K (+0.78 %) |
Nov 17 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Sell | S | 29.07 | 7,000 | 203,462 | 640,987 | 648 K to 641 K (-1.08 %) |
Nov 17 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Buy | M | 5.33 | 7,000 | 37,310 | 647,987 | 641 K to 648 K (+1.09 %) |
Nov 02 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Option Exercise | M | 5.33 | 12,000 | 63,960 | 267,000 | |
Nov 02 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Sell | S | 25.96 | 12,000 | 311,568 | 640,987 | 653 K to 641 K (-1.84 %) |
Nov 02 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Buy | M | 5.33 | 12,000 | 63,960 | 652,987 | 641 K to 653 K (+1.87 %) |
Oct 17 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Option Exercise | M | 5.33 | 12,000 | 63,960 | 279,000 | |
Oct 17 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Sell | S | 24.00 | 12,000 | 288,000 | 640,987 | 653 K to 641 K (-1.84 %) |
Oct 17 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Buy | M | 5.33 | 12,000 | 63,960 | 652,987 | 641 K to 653 K (+1.87 %) |
Oct 04 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Option Exercise | M | 5.33 | 12,000 | 63,960 | 291,000 | |
Oct 04 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Option Exercise | A | 23.46 | 1,505 | 35,307 | 1,505 | |
Oct 04 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Option Exercise | M | 19.58 | 1,771 | 34,676 | 0 | |
Oct 04 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Sell | S | 23.37 | 12,000 | 280,476 | 640,987 | 653 K to 641 K (-1.84 %) |
Oct 04 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Buy | M | 5.33 | 12,000 | 63,960 | 652,987 | 641 K to 653 K (+1.87 %) |
Oct 04 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Payment of Exercise | F | 23.03 | 1,612 | 37,124 | 640,987 | 642.6 K to 641 K (-0.25 %) |
Oct 04 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Buy | M | 19.58 | 1,771 | 34,676 | 642,599 | 640.8 K to 642.6 K (+0.28 %) |
Sep 19 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Option Exercise | M | 5.33 | 5,000 | 26,650 | 303,000 | |
Sep 19 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Option Exercise | M | 5.33 | 2,000 | 10,660 | 308,000 | |
Sep 19 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Option Exercise | M | 5.33 | 2,000 | 10,660 | 310,000 | |
Sep 19 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Option Exercise | M | 5.33 | 3,000 | 15,990 | 312,000 | |
Sep 19 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Sell | S | 24.23 | 5,000 | 121,160 | 640,828 | 645.8 K to 640.8 K (-0.77 %) |
Sep 19 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Buy | M | 5.33 | 5,000 | 26,650 | 645,828 | 640.8 K to 645.8 K (+0.78 %) |
Sep 19 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Sell | S | 23.87 | 2,000 | 47,730 | 640,828 | 642.8 K to 640.8 K (-0.31 %) |
Sep 19 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Buy | M | 5.33 | 2,000 | 10,660 | 642,828 | 640.8 K to 642.8 K (+0.31 %) |
Sep 19 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Sell | S | 23.74 | 2,000 | 47,480 | 640,828 | 642.8 K to 640.8 K (-0.31 %) |
Sep 19 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Buy | M | 5.33 | 2,000 | 10,660 | 642,828 | 640.8 K to 642.8 K (+0.31 %) |
Sep 19 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Sell | S | 23.66 | 3,000 | 70,980 | 640,828 | 643.8 K to 640.8 K (-0.47 %) |
Sep 19 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Buy | M | 5.33 | 3,000 | 15,990 | 643,828 | 640.8 K to 643.8 K (+0.47 %) |
Sep 06 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Option Exercise | M | 5.33 | 12,000 | 63,960 | 315,000 | |
Sep 06 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Sell | S | 22.72 | 12,000 | 272,640 | 640,828 | 652.8 K to 640.8 K (-1.84 %) |
Sep 06 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Buy | M | 5.33 | 12,000 | 63,960 | 652,828 | 640.8 K to 652.8 K (+1.87 %) |
Aug 16 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Option Exercise | M | 5.33 | 12,000 | 63,960 | 327,000 | |
Aug 16 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Sell | S | 20.20 | 12,000 | 242,412 | 640,828 | 652.8 K to 640.8 K (-1.84 %) |
Aug 16 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Buy | M | 5.33 | 12,000 | 63,960 | 652,828 | 640.8 K to 652.8 K (+1.87 %) |
Aug 03 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Option Exercise | M | 5.33 | 7,000 | 37,310 | 339,000 | |
Aug 03 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Option Exercise | M | 5.33 | 5,000 | 26,650 | 346,000 | |
Aug 03 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Sell | S | 21.60 | 7,000 | 151,200 | 640,828 | 647.8 K to 640.8 K (-1.08 %) |
Aug 03 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Buy | M | 5.33 | 7,000 | 37,310 | 647,828 | 640.8 K to 647.8 K (+1.09 %) |
Aug 03 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Sell | S | 21.54 | 5,000 | 107,700 | 640,828 | 645.8 K to 640.8 K (-0.77 %) |
Aug 03 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Buy | M | 5.33 | 5,000 | 26,650 | 645,828 | 640.8 K to 645.8 K (+0.78 %) |
Jul 19 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Option Exercise | M | 5.33 | 12,000 | 63,960 | 351,000 | |
Jul 19 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Sell | S | 21.10 | 12,000 | 253,224 | 640,828 | 652.8 K to 640.8 K (-1.84 %) |